Monday, 21 September 2026European Markets

PCI BIOTECH HOLD Stock Went Down By Over 11% So Far Today

Loading stream...

(VIANEWS) - Shares of PCI BIOTECH HOLD (Oslo Børs All-share Index_GI: PCIB.OL) dropped by a staggering 11.17% to kr2.67 at 13:39 EST on Monday, after three successive sessions in a row of gains. Oslo Børs All-share Index_GI is rising 0.04% to kr1,403.08, after five consecutive sessions in a row of losses. This seems, up to now, a somewhat positive trend trading session today.

PCI BIOTECH HOLD's last close was kr3.00, 49.66% under its 52-week high of kr5.96.

About PCI BIOTECH HOLD

PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform. The company develops anticancer paradigms, including fimaCHEM, a chemotherapeutics for treatment of cancer; fimaVACC, a T-cell induction technology for therapeutic vaccination, which is in Phase I clinical study; and fimaNAc, a nucleic acid therapeutics delivery technology, which is in pre-clinical study. It also offers Amphinex, a photosensitiser fimaporfin. The company has collaborative research programs with Bavarian Nordic, BioNTech, Phio Pharmaceuticals, DCprime, eTheRNA immunotherapies, IMV, and Aposense. PCI Biotech Holding ASA is based in Oslo, Norway.

Earnings Per Share

As for profitability, PCI BIOTECH HOLD has a trailing twelve months EPS of kr-1.937.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -64.36%.

Moving Average

PCI BIOTECH HOLD's worth is way above its 50-day moving average of kr2.41 and below its 200-day moving average of kr2.94.

Yearly Top and Bottom Value

PCI BIOTECH HOLD's stock is valued at kr2.67 at 13:39 EST, way below its 52-week high of kr5.96 and way higher than its 52-week low of kr1.52.

Volatility

PCI BIOTECH HOLD's last week, last month's, and last quarter's current intraday variation average was a positive 7.35%, a negative 0.30%, and a positive 7.39%.

PCI BIOTECH HOLD's highest amplitude of average volatility was 11.51% (last week), 8.46% (last month), and 7.39% (last quarter).

More news about PCI BIOTECH HOLD (PCIB.OL).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Frontier AI Slowdown Call Splits Industry, Rattles Capex-Sensitive Markets
Anthropic's Dario Amodei publicly called for a coordinated global slowdown in frontier AI development, a stance Microsoft echoed with a 'humanist' AI code of conduct, but Nvidia and Meta's CEOs rejected any coordinated pause days later, exposing a widening rift between safety-focused and growth-focused AI leaders. The dispute landed amid growing financial scrutiny of AI infrastructure spending — a hyperscaler capex analysis, FTC warnings against antitrust waivers for AI firms, and an 8.6% single-day stock drop in GE Vernova tied directly to the slowdown remarks — signaling investors are newly nervous about whether the AI capex boom (including Alphabet's projected $701B revenue narrative) can be justified if the pace of development itself becomes contested.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,983
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,983 facts checked against source5,304 source documents archived
Query this data → isubstrate.com